Biovail Corp. International regulatory update

Canada granted marketing approval for BVF's Brexidol piroxicam-beta-cyclodextrin, a non-steroidal anti-inflammatory drug (NSAID) to treat mild to severe acute pain. BVF's Crystaal division will marke...